MICHAEL RAPP - 28 May 2021 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
28 May 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 20:04:09 UTC
Previous filing
26 May 2021
Next filing
13 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +3,750 $0.000000 3,750 28 May 2021 Common Stock 3,750 $20.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest 25% every quarter after the grant date.